Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.

Zhan XH, Jiao JW, Zhang HF, Li CQ, Zhao JM, Liao LD, Wu JY, Wu BL, Wu ZY, Wang SH, Du ZP, Shen JH, Zou HY, Neufeld G, Xu LY, Li EM.

Cancer Med. 2017 Jul;6(7):1707-1719. doi: 10.1002/cam4.1096. Epub 2017 May 29.

2.

Network Analyses of Gene Expression following Fascin Knockdown in Esophageal Squamous Cell Carcinoma Cells.

Du ZP, Wu BL, Xie JJ, Lin XH, Qiu XY, Zhan XF, Wang SH, Shen JH, Li EM, Xu LY.

Asian Pac J Cancer Prev. 2015;16(13):5445-51.

3.

Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.

Bai YQ, Zhang JY, Bai CY, Xu XE, Wu JY, Chen B, Wu ZY, Wang SH, Shen J, Shen JH, Yao XD, Gao LZ, Wu B, Gu HL, Liu XH, Li X, Li EM, Xu LY.

Acta Histochem Cytochem. 2015 Jun 29;48(3):75-81. doi: 10.1267/ahc.14054. Epub 2015 Jun 25.

4.

A systematic analysis of human lipocalin family and its expression in esophageal carcinoma.

Du ZP, Wu BL, Wu X, Lin XH, Qiu XY, Zhan XF, Wang SH, Shen JH, Zheng CP, Wu ZY, Xu LY, Wang D, Li EM.

Sci Rep. 2015 Jul 1;5:12010. doi: 10.1038/srep12010.

5.

Preliminary Design and Evaluation of a B-Scan OCT-Guided Needle.

Joos KM, Shen JH.

Photonics. 2014 Sep;1(3):260-266.

6.

Evaluation of microsurgical tasks with OCT-guided and/or robot-assisted ophthalmic forceps.

Yu H, Shen JH, Shah RJ, Simaan N, Joos KM.

Biomed Opt Express. 2015 Jan 9;6(2):457-72. doi: 10.1364/BOE.6.000457. eCollection 2015 Feb 1.

7.

A three-protein signature and clinical outcome in esophageal squamous cell carcinoma.

Cao HH, Zhang SY, Shen JH, Wu ZY, Wu JY, Wang SH, Li EM, Xu LY.

Oncotarget. 2015 Mar 10;6(7):5435-48.

8.

A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma.

Peng ZM, Yu W, Xie Y, Peng WH, Cao HH, Shen JH, Wu ZY, Li EM, Xu LY.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5950-9. eCollection 2014.

9.

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Sun LL, Wu JY, Wu ZY, Shen JH, Xu XE, Chen B, Wang SH, Li EM, Xu LY.

Int J Cancer. 2015 Mar 15;136(6):E569-77. doi: 10.1002/ijc.29211. Epub 2014 Sep 24.

10.

Shortest path analyses in the protein-protein interaction network of NGAL (neutrophil gelatinase-associated lipocalin) overexpression in esophageal squamous cell carcinoma.

Du ZP, Wu BL, Wang SH, Shen JH, Lin XH, Zheng CP, Wu ZY, Qiu XY, Zhan XF, Xu LY, Li EM.

Asian Pac J Cancer Prev. 2014;15(16):6899-904.

11.

A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.

Cao HH, Zheng CP, Wang SH, Wu JY, Shen JH, Xu XE, Fu JH, Wu ZY, Li EM, Xu LY.

PLoS One. 2014 Aug 25;9(8):e106007. doi: 10.1371/journal.pone.0106007. eCollection 2014.

12.

ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.

Xie JJ, Xie YM, Chen B, Pan F, Guo JC, Zhao Q, Shen JH, Wu ZY, Wu JY, Xu LY, Li EM.

Oncotarget. 2014 Sep 30;5(18):8569-82.

13.

Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.

Li LY, Li EM, Wu ZY, Cao HH, Shen JH, Xu XE, Chen B, Wu JY, Xu LY.

Int J Clin Exp Pathol. 2014 May 15;7(6):3132-40. eCollection 2014.

14.

The prognostic implications of microvascular density and lymphatic vessel density in esophageal squamous cell carcinoma: Comparative analysis between the traditional whole sections and the tissue microarray.

Chen B, Fang WK, Wu ZY, Xu XE, Wu JY, Fu JH, Yao XD, Huang JH, Chen JX, Shen JH, Zheng CP, Wang SH, Li EM, Xu LY.

Acta Histochem. 2014 May;116(4):646-53. doi: 10.1016/j.acthis.2013.12.003. Epub 2014 Jan 9.

PMID:
24411070
15.

Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.

Xu YW, Peng YH, Chen B, Wu ZY, Wu JY, Shen JH, Zheng CP, Wang SH, Guo HP, Li EM, Xu LY.

Am J Gastroenterol. 2014 Jan;109(1):36-45. doi: 10.1038/ajg.2013.384. Epub 2013 Dec 3.

16.

Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Sun LL, Holowatyj A, Xu XE, Wu JY, Wu ZY, Shen JH, Wang SH, Li EM, Yang ZQ, Xu LY.

Am J Cancer Res. 2013 Nov 1;3(5):509-17. eCollection 2013.

17.

Miniature real-time intraoperative forward-imaging optical coherence tomography probe.

Joos KM, Shen JH.

Biomed Opt Express. 2013 Jul 16;4(8):1342-50. doi: 10.1364/BOE.4.001342. eCollection 2013.

18.

κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.

Zhang YF, Xu QX, Liao LD, Xu XE, Wu JY, Shen J, Wu ZY, Shen JH, Li EM, Xu LY.

Hum Pathol. 2013 Sep;44(9):1756-65. doi: 10.1016/j.humpath.2012.11.025. Epub 2013 Apr 8.

PMID:
23574786
19.

Overexpression of Jumonji AT-rich interactive domain 1B and PHD finger protein 2 is involved in the progression of esophageal squamous cell carcinoma.

Sun LL, Sun XX, Xu XE, Zhu MX, Wu ZY, Shen JH, Wu JY, Huang Q, Li EM, Xu LY.

Acta Histochem. 2013 Jan;115(1):56-62. doi: 10.1016/j.acthis.2012.04.001. Epub 2012 Apr 23.

PMID:
22534467
20.

Overexpression of sigma1 receptor and its positive associations with pathologic TNM classification in esophageal squamous cell carcinoma.

Xu QX, Li EM, Zhang YF, Liao LD, Xu XE, Wu ZY, Shen JH, Xu LY.

J Histochem Cytochem. 2012 Jun;60(6):457-66. doi: 10.1369/0022155412443542. Epub 2012 Apr 17.

Supplemental Content

Loading ...
Support Center